OmniAb, Inc. Sustainability Profile
OmniAb, Inc., headquartered in the United States, is a leading biotechnology company specialising in the development of innovative antibody discovery platforms. Founded in 2018, OmniAb has rapidly established itself in the biopharmaceutical industry, focusing on providing unique solutions for therapeutic antibody development. The company’s core offerings include its proprietary OmniAb platform, which enables the generation of fully human antibodies with high specificity and affinity. This technology sets OmniAb apart, allowing for accelerated drug discovery processes and enhanced therapeutic efficacy. With a strong market position, OmniAb has achieved significant milestones, including strategic partnerships and collaborations that bolster its presence in major operational regions across North America and Europe. The company continues to drive advancements in antibody therapeutics, positioning itself as a key player in the evolving landscape of biomedicine.
DitchCarbon Score
How does OmniAb, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
OmniAb, Inc.'s score of 25 is lower than 60% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
OmniAb, Inc.'s reported carbon emissions
OmniAb, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Consequently, there are no documented Scope 1, 2, or 3 emissions or any reduction targets or achievements available for review. In the context of climate commitments, OmniAb, Inc. has not outlined any specific climate pledges or initiatives aimed at reducing carbon emissions. The lack of data suggests that the company may still be in the early stages of developing a comprehensive sustainability strategy or reporting framework. As there are no emissions data or reduction initiatives cascaded from a parent organisation, OmniAb, Inc. stands alone in its current reporting status. The company may benefit from establishing measurable targets and engaging in industry-standard climate initiatives to enhance its environmental impact and transparency.
How Carbon Intensive is OmniAb, Inc.'s Industry?
How Carbon Intensive is OmniAb, Inc.'s Location?
OmniAb, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
OmniAb, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
